Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

The franchise drug for autoimmune disorders such as dermatitis could face a challenger: A candidate from Apogee Therapeutics.

Today, Crohn’s injections are easy to administer — and relatively painless. Here’s what you can expect and how to make the process easier.

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

There's a lot of exciting therapies that have emerged over the last 10 years and there's more therapies coming down the pipeline. And so, especially because I see predominantly kids, I'm really ...

Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...

Medicare should cover epidural steroid injections to relieve spinal pain caused by certain conditions lasting at least 4 weeks despite other treatment.

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The approval of Dupixent for bullous pemphigoid is expected to offer new hope to patients who have previously faced limited treatment options. With the potential to effectively manage symptoms and ...